Neck Pain
Pain·MeSH: Neck Pain
Prevalence
2721.8 / 100K
Incidence
570.4 / 100K/yr
1 drug in development·1 company·10 clinical trials
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| MYOBLOC | SUPERNUS PHARMACEUTICALS, INC. (SUPN) |
Frequently asked questions
How many drugs are in development for Neck Pain?
BioSniper tracks 1 drug in development for Neck Pain across 1 company.
How many clinical trials target Neck Pain?
There are 10 clinical trials targeting Neck Pain tracked by BioSniper.
What is the prevalence of Neck Pain?
The estimated prevalence of Neck Pain is approximately 2721.8 per 100,000 population.
Deep-dive into Neck Pain
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis